U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C3H7NO2
Molecular Weight 89.0932
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALANINE, DL-

SMILES

CC(N)C(O)=O

InChI

InChIKey=QNAYBMKLOCPYGJ-UHFFFAOYSA-N
InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)

HIDE SMILES / InChI

Molecular Formula C3H7NO2
Molecular Weight 89.0932
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

PubMed

PubMed

TitleDatePubMed
Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation.
2001-05-18
An intrahelical salt bridge within the trigger site stabilizes the GCN4 leucine zipper.
2001-04-27
Different usage of the glycosaminoglycan attachment sites of biglycan.
2001-04-20
Characterization of a phospholipase C beta 2-binding site near the amino-terminal coiled-coil of G protein beta gamma subunits.
2001-04-06
Disruption of an active site hydrogen bond converts human heme oxygenase-1 into a peroxidase.
2001-04-06
The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity.
2001-04-06
Interacting fidelity defects in the replicative DNA polymerase of bacteriophage RB69.
2001-03-30
Construction of a high affinity zinc binding site in the metabotropic glutamate receptor mGluR1: noncompetitive antagonism originating from the amino-terminal domain of a family C G-protein-coupled receptor.
2001-03-30
Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase: insights into kinase mechanism.
2001-03-30
Scanning mutagenesis reveals roles for helix n of the bacteriophage T7 RNA polymerase thumb subdomain in transcription complex stability, pausing, and termination.
2001-03-30
Role of two histidines in the (6-4) photolyase reaction.
2001-03-30
Hydrogen exchange nuclear magnetic resonance spectroscopy mapping of antibody epitopes on the house dust mite allergen Der p 2.
2001-03-23
The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains.
2001-03-23
Roles for the C-terminal region of sigma 54 in transcriptional silencing and DNA binding.
2001-03-23
Requirements and effects of palmitoylation of rat PLD1.
2001-03-23
Functional rescue of the nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutants G185C and R202C by a second site suppressor mutation.
2001-03-16
The regulation of type 7 adenylyl cyclase by its C1b region and Escherichia coli peptidylprolyl isomerase, SlyD.
2001-03-16
Regulation of ROMK1 channels by protein-tyrosine kinase and -tyrosine phosphatase.
2001-03-09
Mutagenic analysis of functional residues in putative substrate-binding site and acidic domains of vacuolar H+-pyrophosphatase.
2001-03-09
Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1).
2001-01-26
The PD...(D/E)XK motif in restriction enzymes: a link between function and conformation.
2001-01-16
Substituting leucine for alanine-86 in the tether region of the iron-sulfur protein of the cytochrome bc1 complex affects the mobility of the [2Fe2S] domain.
2001-01-16
Short, solubilized polyalanines are conformational chameleons: exceptionally helical if N- and C-capped with helix stabilizers, weakly to moderately helical if capped with rigid spacers.
2001-01-16
Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis.
2001-01-12
Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites.
2001-01-09
Vitamin B12 and hepatic enzyme serum levels correlate in male alcohol-dependent patients.
2001-01-05
The role of nitric oxide in bradycardia of rats with obstructive cholestasis.
2001-01-05
Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK(2) receptor: the role of natural residues and their chirality.
2001-01-01
Ligand binding to integrin alpha(v)beta(3) requires tyrosine 178 in the alpha(v) subunit.
2001-01-01
Microdialysis study of amino acid neurotransmitters in the spinal dorsal horn of patients undergoing microsurgical dorsal root entry zone lesioning. Technical note.
2001-01
Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome.
2001-01
Comparative antiplatelet efficacy of a novel, nonpeptide GPIIb/IIIa antagonist (XV454) and abciximab (c7E3) in flow models of thrombosis.
2001-01
Reactivation of viral replication after liver resection in patients infected with hepatitis B virus.
2001-01
Oral glycoprotein IIb/IIIa antagonists in coronary artery disease.
2001-01
Low-dose IGF-I has no selective advantage over insulin in regulating glucose metabolism in hyperglycemic depancreatized dogs.
2001-01
Neutrophils, not complement, mediate the mortality of experimental hemorrhagic pancreatitis.
2001-01
Viral markers and use of factor products among Finnish patients with bleeding disorders.
2001-01
Experimental study of a type 3 phosphodiesterase inhibitor on liver graft function.
2001-01
Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon.
2001-01
High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.
2001-01
Chronic hepatitis C in different populations: similar patterns of alanine aminotransferase alteration characterize similar clinical subgroups.
2001-01
Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
2001-01
Fas/CD95 pathway induces mouse liver regeneration and allows for highly efficient retrovirus-mediated gene transfer.
2001-01
Hepatic neovascularization after partial portal vein ligation: novel mechanism of chronic regulation of blood flow.
2001-01
Engineering the active site of ascorbate peroxidase.
2001-01
Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia.
2001-01
Epidermal growth factor reduces multiorgan failure induced by thioacetamide.
2001-01
Zaltoprofen prevents carbon tetrachloride-induced reduction of body weight in rats.
2001-01
Novel mutations in the GALK1 gene in patients with galactokinase deficiency.
2001
Is the Ala138Gly alteration of MEFV gene important for amyloidosis?
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:34:26 GMT 2025
Edited
by admin
on Mon Mar 31 17:34:26 GMT 2025
Record UNII
1FU7983T0U
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DL-ALANINE
FCC  
Preferred Name English
ALANINE, DL-
Systematic Name English
FEMA NO. 3818
Code English
DL-ALPHA-ALANINE
Common Name English
(R,S)-ALANINE
Common Name English
(±)-ALANINE
Systematic Name English
NSC-7602
Code English
DL-ALANINE [FCC]
Common Name English
(±)-2-AMINOPROPANOIC ACID
Systematic Name English
ALANINE DL-FORM [MI]
Common Name English
DL-.ALPHA.-AMINOPROPIONIC ACID
Common Name English
(±)-2-AMINOPROPIONIC ACID
Systematic Name English
Classification Tree Code System Code
CFR 21 CFR 172.540
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
JECFA EVALUATION DL-ALANINE
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
NCI_THESAURUS C29596
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
Code System Code Type Description
FDA UNII
1FU7983T0U
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
PUBCHEM
602
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
CAS
302-72-7
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
EPA CompTox
DTXSID6031255
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
RXCUI
1546161
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY RxNorm
NCI_THESAURUS
C61731
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
JECFA MONOGRAPH
1425
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
NSC
7602
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
DRUG CENTRAL
4306
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
MERCK INDEX
m1467
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
206-126-4
Created by admin on Mon Mar 31 17:34:26 GMT 2025 , Edited by admin on Mon Mar 31 17:34:26 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY